Impact of COVID-19 on Access to Care: A National Patient Survey

Abstract

Keywords

COVID-19 dermatology care access health services research

Get full access to this article

View all access options for this article.

References

Chen

Pradhan

Xue

. What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? J Am Acad Dermatol. 2020;82(4):1034. doi:10.1016/j.jaad.2020.02.030

32081700

Wollina

. Challenges of COVID‐19 pandemic for dermatology. Dermatol Ther. 2020;33(5).doi:10.1111/dth.13430

Price

KN.

Thiede

Shi

VY.

Curiel-Lewandrowski

. Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic. J Am Acad Dermatol. 2020;82(6):e207-e209.doi:10.1016/j.jaad.2020.03.089

32277972

Brownstone

ND.

Thibodeaux

QG.

Reddy

et al. Novel coronavirus disease (COVID-19) and biologic therapy in psoriasis: infection risk and patient counseling in uncertain times. Dermatol Ther. 2020:1-11.doi:10.1007/s13555-020-00377-9

32300516

Amerio

Prignano

Giuliani

Gualdi

. COVID-19 and psoriasis: should we fear for patients treated with biologics? Dermatol Ther. 2020;33(4):e13434. doi:10.1111/dth.13434

32314483

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB